PROSTATE-CANCER SURVEILLANCE - A COST-EFFECTIVE STRATEGY

  • Authors:
    • DV SCHAPIRA
    • AR JARRETT
  • View Affiliations

  • Published online on: March 1, 1993     https://doi.org/10.3892/ijo.2.3.473
  • Pages: 473-477
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The intention of a surveillance program to monitor prostate cancer patients is to detect recurrence of disease as soon as possible and institute therapy at the time of recurrence in order to improve the chance of cure or extend survival. We analyzed the cost of four surveillance programs for prostate cancer. As PSA levels are more sensitive than the bone scan, prostatic acid phosphatase and alkaline phosphatase, a surveillance program which utilizes these latter tests provides no additional clinically useful information beyond a PSA level and is costly. Adopting a strategy of eliminating these tests from a surveillance program would reduce national annual expense by approximately $1.5 billion in the year 2000.

Related Articles

Journal Cover

March 1993
Volume 2 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
SCHAPIRA D and SCHAPIRA D: PROSTATE-CANCER SURVEILLANCE - A COST-EFFECTIVE STRATEGY. Int J Oncol 2: 473-477, 1993
APA
SCHAPIRA, D., & SCHAPIRA, D. (1993). PROSTATE-CANCER SURVEILLANCE - A COST-EFFECTIVE STRATEGY. International Journal of Oncology, 2, 473-477. https://doi.org/10.3892/ijo.2.3.473
MLA
SCHAPIRA, D., JARRETT, A."PROSTATE-CANCER SURVEILLANCE - A COST-EFFECTIVE STRATEGY". International Journal of Oncology 2.3 (1993): 473-477.
Chicago
SCHAPIRA, D., JARRETT, A."PROSTATE-CANCER SURVEILLANCE - A COST-EFFECTIVE STRATEGY". International Journal of Oncology 2, no. 3 (1993): 473-477. https://doi.org/10.3892/ijo.2.3.473